Compound libraries
Detailed information on the rationale behind the design of the compounds, the novelty, the calculated properties and the availability can be obtained at Asclepia MedChem Solutions. The libraries are available on a non-exclusive or exclusive basis. Cherry-picking is possible. IP rights are owned by the customer.
Library code
|
Target class
|
Status |
N° of compounds
|
Stock
|
Average purity
|
LIB-AMCS-001 |
Kinases_Type I
|
In stock |
52
|
5-240 mg
|
97.5%
|
LIB-AMCS-002 |
Kinases_Type I
|
In stock |
130
|
1-108 mg
|
98.0%
|
LIB-AMCS-003 |
Kinases_Type I
|
In stock |
88
|
1-100 mg
|
98.0%
|
LIB-AMCS-004 |
Kinases_Type I
|
In stock |
104
|
2-114 mg
|
96.5%
|
LIB-AMCS-005 |
Kinases_Type I
|
In stock |
61
|
1-122 mg
|
95.5%
|
LIB-AMCS-006 |
Kinases_Type I
|
In stock |
61
|
1-106 mg
|
95.0%
|
LIB-AMCS-007 |
Kinases_Type I
|
In stock |
114
|
1-79 mg
|
96.5%
|
LIB-AMCS-008 |
Kinases_Type I
|
In stock |
54
|
1-89 mg
|
97.5%
|
LIB-AMCS-009 |
Kinases_Type I
|
In stock |
414
|
1-108 mg
|
95.5%
|
LIB-AMCS-010 |
Kinases_Type I
|
In stock |
22
|
1-23 mg
|
95.5%
|
LIB-AMCS-011 |
GPCR
|
In stock |
55
|
1-64 mg
|
96.5%
|
LIB-AMCS-012 |
Kinases_Type I
|
In stock |
21
|
2-85 mg
|
95.0%
|
LIB-AMCS-013 |
Kinases_Type I
|
In stock |
35
|
1-63 mg
|
97.0%
|
LIB-AMCS-014 |
Kinases_Type I
|
In stock |
19
|
2-67 mg
|
96.5%
|
LIB-AMCS-015 |
Voltage gated ion channels
|
In stock |
202
|
1-152 mg
|
97.0%
|
LIB-AMCS-016 |
Phosphodiesterases
|
In stock |
29
|
2-42 mg
|
96.0%
|
LIB-AMCS-017 |
Kinases_Type I
|
In stock |
58
|
1-91 mg
|
94.5%
|
LIB-AMCS-018 |
Phosphodiesterases
|
In stock |
67
|
1-116 mg
|
96.5%
|
LIB-AMCS-019 |
Phosphodiesterases
|
In stock |
71
|
1-116 mg
|
97.0%
|
LIB-AMCS-020 |
Phosphodiesterases
|
In stock |
41
|
1-60 mg
|
96.5%
|
LIB-AMCS-021 |
Phosphodiesterases
|
In stock |
272
|
1-109 mg
|
96.0%
|
LIB-AMCS-022 |
Kinases_Type I
|
In stock |
31
|
1-70 mg
|
95.5%
|
LIB-AMCS-023 |
Kinases_Allosteric or Type I
|
In stock |
295
|
1-124 mg
|
96.5%
|
LIB-AMCS-024 |
Kinases_Allosteric or Type I
|
In stock |
43
|
1-108 mg
|
97.0%
|
LIB-AMCS-025 |
Kinases_Allosteric or Type I
|
In stock |
63
|
1-57 mg
|
96.5%
|
LIB-AMCS-026 |
Kinases_Allosteric or Type I
|
In stock |
37
|
2-102 mg
|
96.5%
|
LIB-AMCS-027 |
Phosphodiesterases
|
In stock |
649
|
1-109 mg
|
96.5%
|
LIB-AMCS-028 |
Kinases_Type I
|
In stock |
258
|
1-137 mg
|
95.5%
|
Library code
|
Target class
|
Status
|
Number
of compounds |
LIB-AMCS-029 |
Kinases_Type I
|
Chemistry validation
|
200
|
LIB-AMCS-030 |
Kinases_Type II
|
Chemistry validation
|
180
|
LIB-AMCS-031 |
Kinases_Allosteric or Type I
|
Chemistry validation
|
240
|
LIB-AMCS-032 |
Kinases_Type I
|
Chemistry validation
|
400
|
LIB-AMCS-033 |
Kinases_Type I
|
Synthesis ongoing
|
200
|
LIB-AMCS-034 |
Kinases_Allosteric or Type I
|
Synthesis ongoing
|
200
|
LIB-AMCS-035 |
Kinases_Type I
|
Chemistry validation
|
200
|
LIB-AMCS-036 |
Voltage gated ion channels
|
Chemistry validation
|
100
|
LIB-AMCS-037 |
Voltage gated ion channels
|
Chemistry validation
|
200
|
LIB-AMCS-038 |
Voltage gated ion channels
|
Chemistry validation
|
200
|
LIB-AMCS-039 |
Voltage gated ion channels
|
Chemistry validation
|
200
|
LIB-AMCS-040 |
Voltage gated ion channels
|
Chemistry validation
|
200
|
LIB-AMCS-041 |
Kinases_Allosteric or Type I
|
Synthesis ongoing
|
200
|
LIB-AMCS-042 |
Kinases_Type I
|
Synthesis ongoing
|
200
|